Established by the United States Congress to support the mission of the NIH—improving health through scientific discovery in the search for cures—the Foundation for NIH is a leader in identifying and addressing complex scientific and health issues. FNIH coordinates the Alzheimer’s Disease Neuroimaging Initiative, a partnership co-funded by the NIH National Institute on Aging and the private sector. Now in its third phase, ADNI studies changes in the brains of people with normal function, mild cognitive impairment and Alzheimer’s.
The Institute of Medicine is an independent, nonprofit organization that works outside of government to provide unbiased and authoritative advice to decision makers and the public. Established in 1970, the IOM is the health arm of the National Academy of Sciences, which was chartered under President Abraham Lincoln in 1863. Nearly 150 years later, the National Academy of Sciences has expanded into what is collectively known as the National Academies, which comprises the National Academy of Sciences, the National Academy of Engineering, the National Research Council, and the IOM.
The IOM asks and answers the nation’s most pressing questions about health and health care.
The Society for Women’s Health Research is the thought leader in research on biological differences in disease and is dedicated to transforming women’s health through science, advocacy, and education.
Founded in 1990 by a group of physicians, medical researchers and health advocates, SWHR aims to bring attention to the myriad of diseases and conditions that affect women uniquely. Due to SWHR’s efforts, women are now routinely included in most major medical research studies and scientists are beginning to consider biological sex as a variable in their research.
Today, SWHR advocates for greater public and private funding for women’s health research and the study of biological differences.
WomenAgainstAlzheimer’s (WA2) is the first national network of women in leadership positions working to speed the pace of research and build real momentum to end Alzheimer’s disease. WA2 harnesses the power and creative energy of women – the disease’s disproportionate victims, as patients and caregivers – to create a new approach to finding a cure and to build a movement that commits our nation to a bold and aggressive plan for the prevention and treatment of Alzheimer’s disease. The WomenAgainstAlzheimer’s research agenda includes a focus on sex-based differences – research that will benefit both women and men.
The Geoffrey Beene Foundation Alzheimer’s Initiative led the formation of the 21st Century BrainTrust™ in 2012 with three other non-profits – BrightFocus Foundation, UsAgainstAlzheimers, and Cleveland Clinic/Lou Ruvo Brain Institute. The 21st Century BrainTrust™ is a virtual research ecosystem designed to empower personal brain health and support early diagnosis using self-administered mobile applications for personal measurement and monitoring of cognition. Think new digital biomarkers mapped using the power of self-administered cognitive testing as a sensitive, early screening tool for all brain traumas, Alzheimer’s and related dementias. The 21st Century BrainTrust™ promotes novel technologies that offer low-cost screening capabilities for future prevention trials to facilitate enrollment as well as exploratory trial endpoints.
BrightFocus™ Foundation is a nonprofit organization supporting research and providing public education to help eradicate brain and eye diseases, including Alzheimer’s disease, macular degeneration, and glaucoma. We are working to save mind and sight.
BrightFocus™ is at the forefront of brain and eye health, advancing early-stage, investigator-initiated research around the world. We also provide free educational materials to people affected by or interested in these diseases, empowering them to take action for themselves and others. They can take advantage of news and research results offered through BrightFocus™ websites, publications, social media, videos, podcasts, and TV and radio public service announcements.
Brigham and Women’s Hospital is world-renowned in virtually every area of adult medicine. As a teaching hospital of Harvard Medical School, our leadership in patient quality and safety, development of state-of-the-art treatments and technologies, and robust research programs have improved the health of people around the world.
Recognized internationally for its excellence in patient care, its outstanding reputation in biomedical research, and its commitment to educating and training physicians, research scientists and other health care professionals, Brigham and Women’s Hospital (BWH) is a 793-bed teaching affiliate of Harvard Medical School located in the heart of Boston’s renowned Longwood Medical Area. Along with its modern inpatient facilities, BWH boasts extensive outpatient services and clinics, neighborhood primary care health centers, state-of-the art diagnostic and treatment technologies and research laboratories.
InnoCentive is the global leader in crowdsourcing innovation problems to the world’s smartest people who compete to provide ideas and solutions to important business, social, policy, scientific, and technical challenges. Our global network of millions of problem solvers, proven challenge methodology, and cloud-based technology combine to help our clients transform their economics of innovation through rapid solution delivery and the development of sustainable open innovation programs. For more than a decade, leading organizations such as AARP Foundation, Air Force Research Labs, Booz Allen Hamilton, Cleveland Clinic, Eli Lilly & Company, EMC Corporation, NASA, Nature Publishing Group, Procter & Gamble, Scientific American, Syngenta, The Economist, Thomson Reuters, and several government agencies in the U.S. and Europe have partnered with InnoCentive to rapidly generate innovative new ideas and solve problems faster, more cost effectively, and with less risk than ever before.